Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-012332

SVP & Chief Scientific Officer sold 3,310 shares at $42.39 ($140,311)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Doberstein Stephen K SVP & Chief Scientific Officer 2019-02-19 Sale −3,310 $42.39 $140,311 99,374 D
Open-market sales · 3,310 sh · avg $42.39 · $140,311
Loading xslF345X03/doc4.xml…